Probenecid induces the recovery of renal ischemia/reperfusion injury via the blockade of Pannexin 1/P2X7 receptor axis

Bibliographic Information
Authors: El-Maadawy W.H.; Hassan M.; Badawy M.H.; AbuSeada A.; Hafiz E.
Journal: Life Sciences
Publisher: Elsevier Inc.
Publication Date: November 2022
Volume / Issue: Volume 308
Article No.: 120933
ISSN: 243205
DOI: 10.1016/j.lfs.2022.120933
Scopus: View on Scopus
PubMed: 36075473
Document Type: Article
Authors and Affiliations
El-Maadawy W.H., Pharmacology Department, Theodor Bilharz Research Institute, Warrak El-Hadar, Imbaba (P.O. 30), Giza, 12411, Egypt; Hassan M., Immunology Department, Theodor Bilharz Research Institute, Warrak El-Hadar, Imbaba (P.O. 30), Giza, 12411, Egypt; Badawy M.H., Urology Department, Theodor Bilharz Research Institute, Warrak El-Hadar, Imbaba (P.O. 30), Giza, 12411, Egypt; AbuSeada A., Anesthesia Department, Theodor Bilharz Research Institute, Warrak El-Hadar, Imbaba (P.O. 30), Giza, 12411, Egypt; Hafiz E., Electron Microscopy Department, Theodor Bilharz Research Institute, Warrak El-Hadar, Imbaba (P.O. 30), Giza, 12411, Egypt
Abstract
Renal ischemia/reperfusion injury (RI/RI) is one of the main driving causes of acute kidney injury. However, effective treatment to limit injury and promote recovery and/or survival is still unavailable. Probenecid (PBN), a drug indicated for refractory gout, exhibits protective activities against several preclinical diseases including cerebral and myocardial I/RI via Pannexin 1 (Panx1) and P2X7 receptors' (P2X7R) inhibition. However, its protective role against RI/RI has not been previously addressed. Accordingly, we subjected rats to bilateral RI/RI with/or without PBN treatment. Twenty-four hours post-reperfusion, PBN showed mild tubular injury and reduced serum nephrotoxicity indices, gene and protein expression levels of Panx 1 and P2X7R, and ATP and pro-inflammatory cytokines' levels. The nucleotide-binding domain-like receptor protein 3 (NLRP3) inflammasome signaling was also downregulated, as demonstrated by reduced gene and protein expression of NLRP3 and caspase-1, along with suppressed IL-1β maturation. Furthermore, PBN enhanced Tregs activity as indicated by elevated FoxP3 gene expression, IL-10, and TGF-β renal levels. On day 5 post-reperfusion, PBN noticeably enhanced renal recovery, as demonstrated by intact tubular epithelium and restored nephrotoxicity indices, Panx 1 and P2X7R gene and protein expression levels, ATP and pro-inflammatory cytokine levels, and NLRP3 inflammasome signaling. Besides, renal Tregs activity was also significantly increased. Our study elaborates for the first time the effectiveness of PBN in recovering post-ischemic renal injury through synergistic inhibition in Panx1/P2X7R axis leading to inactivation of NLRP3 inflammasome signaling and activation of Tregs in ischemic renal tissues. Therefore, PBN can be considered a promising drug for RI/RI treatment. © 2022 Elsevier Inc.
Keywords
NLRP3 inflammasome; P2X7 receptors; Pannexin 1 channels; Probenecid; Renal ischemia/reperfusion injury; Tregs; Adenosine Triphosphate; Animals; Caspase 1; Cytokines; Forkhead Transcription Factors; Inflammasomes; Interleukin-10; Ischemia; Kidney; NLR Family, Pyrin Domain-Containing 3 Protein; Nucleotides; Rats; Receptors, Purinergic P2X7; Reperfusion Injury; Transforming Growth Factor beta; interleukin 10; membrane protein; pannexin 1; purinergic P2X7 receptor; transcription factor FOXP3; unclassified drug; cryopyrin; cytokine; forkhead transcription factor; inflammasome; interleukin 1beta converting enzyme; nucleotide; animal experiment; animal model; animal tissue; Article; controlled study; down regulation; gene expression level; male; nephrotoxicity; nonhuman; protein expression level; rat; renal ischemia reperfusion injury; single drug dose; animal; metabolism
Citation Information
Scopus Citations: 17
For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.
The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.
English Website: https://www.tbri.sci.eg/en/
Arabic Website: https://www.tbri.sci.eg/ar/
Prepared and Uploaded by:
Abdalla F. Abdalla
Electronic Portal Unit
